SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is facing significant volatility and intense community debate after announcing a massive equity offering to fund a large backlog of AI server orders. While some investors view the dilution as a necessary step to capitalize on strong demand, others are expressing frustration over the timing and the company's long-standing governance concerns.

iShares Silver Trust - Fractional undivided beneficial interests

iShares Silver Trust

The iShares Silver Trust (SLV) is facing intense selling pressure as a strengthening USD, surging treasury yields, and broader market volatility drive investors to liquidate precious metals positions. The community remains deeply divided, with some investors aggressively accumulating physical silver as a long-term hedge against potential inflation, while others view the recent price drop as evidence that silver has failed as a reliable store of value.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending as investors debate the impact of upcoming DEA rescheduling hearings against the company's aggressive pivot toward an alcohol-focused strategy. The community remains deeply divided, with many expressing intense frustration over dilution and leadership performance while others point to the potential for a long-term infrastructure play in the U.S. market.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors react to strong growth data for its Predictions platform, with community discussions heavily focused on the potential for massive engagement during the upcoming World Cup and the strategic advantage of operating in states where traditional sports betting remains restricted. Despite this optimism, the stock remains a subject of intense debate, as shareholders weigh the company's long-term profitability and competitive positioning against persistent frustration with management and stagnant price action over recent years.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is seeing strong investor interest driven by positive Phase 1 data for its subcutaneous BRIUMVI treatment in Myasthenia Gravis and ongoing speculation regarding a potential buyout. The community is actively discussing the company's expanding addressable market, potential acquisition targets, and the strategic positioning of its product pipeline against competitors.

Cracker Barrel Old Country Store, Inc. engages in the operation and development of restaurant and retail outlets. The format of its stores consists of a trademarked rustic old country-store design that offers restaurant menu featuring home-style country food. The company was founded by Dan W. Evins on September 19, 1969 and is headquartered in Lebanon, TN.

Cracker Barrel Old Country Store Inc

Cracker Barrel is seeing significant volatility as market participants debate its turnaround potential following a stronger-than-expected earnings beat and raised guidance. Investors are actively discussing the company's efforts to address declining traffic and margin pressures, with the high level of short interest fueling speculation about a potential squeeze while some remain skeptical of long-term stability.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as investor sentiment builds ahead of an earnings release, fueled by excitement over recent patent extensions and anticipated approvals in the European market. Community discussion is focused on the stock's undervaluation, potential for a buyout, and the strong momentum leading into the company's financial update.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is facing intense debate from retail investors as recent selling activity by ARK Invest triggers concerns over the company's timeline for commercializing its 'Midnight' aircraft. While some participants are wary of the stock's sluggish technical progress compared to competitors, others are aggressively buying the dip, banking on long-term institutional backing and the anticipation of near-term catalysts like FAA milestones and defense partnerships.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors debate the stock's future amid ongoing geopolitical tensions and heavy scrutiny of the company's valuation. Community discussion is sharply divided between supporters highlighting potential future catalysts and critics emphasizing the firm's lack of fundamentals and its reliance on the personal brand of Donald Trump.

Vanguard Index Funds - Vanguard S&P 500 ETF

Vanguard S&P 500 ETF

Vanguard's VOO has hit a historic $1 trillion milestone, cementing its status as a cornerstone of passive investing as retail and institutional investors continue to favor broad index exposure. Community discussion remains focused on long-term wealth compounding versus short-term trading, with many investors leaning into the 'VOO and chill' strategy to navigate current market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse technology using proprietary nanosecond pulsed field ablation (nsPFA) energy, today announced plans to participate in the upcoming Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach, FL. Pulse Biosciences Management is...

Here's Why Pulse Biosciences, Inc (PLSE) is a Great Momentum Stock to Buy

Does Pulse Biosciences, Inc (PLSE) have what it takes to be a top stock pick for momentum investors? Let's find out.

Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors.

Pulse Biosciences CEO Bought 15,000 Company Shares. Here's What That Means for Investors...

ATM Equity Purchases by Pulse Biosciences Co-Chairmen Total Approximately $13.3 Million

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse technology using proprietary nanosecond pulsed field ablation (nsPFA) energy, today announced its Co-Chairmen of the Board, Robert Duggan...

Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse technology using proprietary nanosecond pulsed field ablation (nsPFA) energy, today announced plans to participate in the upcoming BofA...

Pulse Biosciences (PLSE) Upgraded to Buy: What Does It Mean for the Stock?

Pulse Biosciences (PLSE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Pulse Biosciences (NASDAQ:PLSE) Announces Quarterly Earnings Results, Beats Estimates By $0.05 EPS

Pulse Biosciences (NASDAQ:PLSE - Get Free Report) issued its earnings results on Monday. The company reported ($0.27) EPS for the quarter, topping analysts' consensus estimates of ($0.32) by $0.05...

Pulse Biosciences, Inc (PLSE) Reports Q1 Loss, Lags Revenue Estimates

Pulse Biosciences (PLSE) delivered earnings and revenue surprises of +15.63% and -19.80%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Pulse Biosciences Reports Business Updates and First Quarter 2026 Financial Results

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of novel nPulse technology using proprietary Nanosecond Pulsed Field Ablation (nanosecond PFA or nsPFA) energy, today announced business updates and...

Pulse Biosciences (PLSE) Expected to Announce Quarterly Earnings on Thursday

Pulse Biosciences (NASDAQ:PLSE) will be releasing its Q1 2026 earnings after the market closes on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-pulse-biosciences-inc-stock...

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Miami, FL.

Current Price	$25.77
Prev Close	$24.84
Open	$24.86
Dividend Yield	0.00%
50-Day Moving Average	$22.72
Beta	1.49
Avg. Volume	391,226.34
PE Ratio	-23.36

52-Week High	$28.53
52-Week Low	$12.56
Market Capitalization	$1.72B
EPS (Annual)	-$1.08
Price to Book	26.52
Revenue Per Employee	$3,017.24

PLSEPulse Biosciences Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PLSE News